BSEOthers31 Jul 2026 · 31 Jul 2026, 08:21 pm
Annual Report for the FY 2025-26
Gland Pharma Ltd · 543245
✦ AI SummaryResults
Gland Pharma Ltd announced its Annual Report for FY 2025-26, with the 448th Annual General Meeting scheduled for August 25, 2025. The meeting will be held through videoconferencing (VC) or other audio-visual means. The company's financial results for the year ended March 31, 2026, will be presented, and the meeting will also consider the financial statements for the year.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Reg. 34 (1) Annual Report.